Cargando…
Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application
Atherosclerosis (AS) is the leading cause of stroke and death worldwide. Although many lipid-lowering or antiplatelet medicines have been used to prevent the devastating outcomes caused by AS, the serious side effects of these medicines cannot be ignored. Moreover, these medicines are aimed at preve...
Autores principales: | Liu, Yandong, Yang, Futang, Zou, Sili, Qu, Lefeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330346/ https://www.ncbi.nlm.nih.gov/pubmed/30666207 http://dx.doi.org/10.3389/fphar.2018.01520 |
Ejemplares similares
-
IGFBP6 Is Downregulated in Unstable Carotid Atherosclerotic Plaques According to an Integrated Bioinformatics Analysis and Experimental Verification
por: Liu, Yandong, et al.
Publicado: (2020) -
Di’ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway
por: Liang, Jiyi, et al.
Publicado: (2022) -
YKL-40 Aggravates Early-Stage Atherosclerosis by Inhibiting Macrophage Apoptosis in an Aven-dependent Way
por: Huan, Wei, et al.
Publicado: (2021) -
Transcriptome sequencing revealed candidate genes relevant to mesenchymal stem cells' role in aortic dissection patients
por: Yang, Junlin, et al.
Publicado: (2018) -
New Insights Into Gut-Bacteria-Derived Indole and Its Derivatives in Intestinal and Liver Diseases
por: Li, Xiaojing, et al.
Publicado: (2021)